Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PLA2G4B | P0C869 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1032834 | 0.74 | ESR1 (0.46) | ALDH1A1KDM4EHSD17B10CYP1A2CYP2C9 | |
| SCHEMBL1033643 | 0.71 | HSPA5 (0.44) | ALDH1A1HSD17B10CYP2C9CYP2C19TDP1 | |
| SCHEMBL112324 | 0.66 | DGKA (0.55) | ALDH1A1PLA2G4B | |
| SCHEMBL11752253 | 0.63 | DGKA (0.52) | ALDH1A1PLA2G4B | |
| SCHEMBL31290498 | 0.63 | POLB (0.50) | ALDH1A1KDM4EHSD17B10CYP1A2CYP2C9 | |
| SCHEMBL25479475 | 0.62 | DGKA (0.55) | ALDH1A1HSD17B10CYP2C9PLA2G4B | |
| SCHEMBL9008209 | 0.62 | NAAA (0.60) | PLA2G4B | |
| SCHEMBL29986668 | 0.62 | NAAA (0.59) | PLA2G4B | |
| SCHEMBL26220850 | 0.62 | DGKA (0.53) | ALDH1A1 | |
| SCHEMBL5014435 | 0.61 | PLA2G4B (0.59) | ALDH1A1HSD17B10PLA2G4BTDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8980134-B2 | Stabilization and surface modification of organic materials | BASF SE (DE) | 2015-03-17 | — | — | US | disclosed |
| US-20110160357-A1 | STABILIZATION AND SURFACE MODIFICATION OF ORGANIC MATERIALS | BASF SE (DE) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160357-A1 | STABILIZATION AND SURFACE MODIFICATION OF ORGANIC MATERIALS | SOD1, EPCAM, AOX1 | ALDH1A1 42/4885KDM4E 1627/4885HSD17B10 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.